ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft survival"

  • 2018 American Transplant Congress

    Cold Ischemia Time is an Important Risk Factor for Post-Liver Transplant Prolonged Length of Stay

    E. Pan, D. Yoeli, N. Galvan, M. Kueht, R. Cotton, C. O'Mahony, J. Goss, A. Rana.

    Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX.

    Background: Cold ischemia time (CIT) is often viewed as a categorical risk factor in liver transplantation. We hypothesize that the risk for adverse outcomes increases…
  • 2018 American Transplant Congress

    Does Prolonged Cold Ischemia Affect Outcomes in Donation after Cardiac Death Kidney Transplants?

    D. Harriman, J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.

    Surgery, Medicine, Pathology, Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC.

    Introduction: Prolonged cold ischemia time (CIT) in the setting of donation after cardiac death (DCD), with requisite warm ischemia time (WIT), produces a 'dual hit'…
  • 2018 American Transplant Congress

    Functional Reconstruction of Urogenital Tissue Defects Using VCA: A Novel Microsurgical Penis Transplant Model and Clinical & Histological Rejection Classification

    S. Fidder,1,4 G. Furtmüller,1 B. Simons,2 B. Kern,1 D. Lough,1 B. Oh,1 M. Chicco,1 C. Brayton,3 W. Lee,1 D. Cooney,1 R. Redett,1 G. Brandacher.1

    1Dept of Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore; 2Dept of Urology, JHU SOM, Baltimore; 3Dept of Molecular & Comparative Pathobiology, JHU SOM, Baltimore; 4Plastic and Reconstructive Surgery, Erasmus University Medical Center, Rotterdam, Netherlands.

    Background: Defects of male urogenital structures subsequent to major trauma are associated with severely reduced function and quality-of-life. As of recent, penis transplantation represents an…
  • 2018 American Transplant Congress

    Impact of Lymphoceles after Kidney Transplantation on Long-Term Outcomes

    L. Lehner, A. Hohberger, F. Halleck, E. Schrezenmeier, D. Khadzhynov, K. Budde, O. Staeck.

    Dept. of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.

    Introduction: Despite preventive methods, lymphoceles are common complications occurring in up to a third of kidney transplant recipients (KTR). A variety of risk factors (surgical,…
  • 2018 American Transplant Congress

    Improvement in Intermediate Graft Survival among Deceased Donor Recipients in the Last Decade Due to Improvements in Outcomes of Higher KDPI Kidney Recipients

    D. Keith.

    Medicine, Sacred Heart Hospital, Pensacola, FL, Turkey.

    Previous research by our group showed that intermediate graft survival of adult deceased donor kidney transplants between six months and three years post-transplant improved in…
  • 2018 American Transplant Congress

    Clinical Significance of Isolated v-Lesions in Kidney Transplantation

    A. Georgalis,1 C. Wehmeier,1 P. Hirt-Minkowski,1 G. Hönger,1 H. Hopfer,2 J. Steiger,1 S. Schaub,1 P. Amico.1

    1Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland; 2Institute for Pathology, University Hospital Basel, Basel, Switzerland.

    Background: Arteritis without significant tubulo-interstitial inflammation (v1-3, but i≤1 and t≤1) is referred by the 10th Banff conference as 'isolated v-lesions'. The clinical significance of…
  • 2018 American Transplant Congress

    Type I NKT Cells Augment Humoral and Cellular Alloimmunity in Response to Hepatocyte Transplantation

    S. Elzein, J. Zimmerer, B. Ringwald, C. Avila, G. Bumgardner.

    Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.

    Hepatocyte transplantation (HcTx) is a potential therapeutic modality for patients with liver disease. Despite examples of antigen acceptance in the liver, allogeneic HcTx into patients…
  • 2018 American Transplant Congress

    Class II Anti-HLA IgG2 and IgG3 DSAs Predict Poorer Outcomes in Chronic Antibody Mediated Rejection of Renal Allografts

    A. Gueret-Wardle,1 G. Lucisano,1 S. Hassan,1 P. Brookes,2 E. Santos-Nunez,2 D. Goodall,1 C. Clarke,1 J. Galliford,1 M. Willicombe,1 D. Taube.1

    1Renal and Transplant Centre, Imperial College London NHS Trust, London, United Kingdom; 2Histocompatibility and Immunogenetics, Imperial College London, London, United Kingdom.

    Introduction: whilst the development of IgG3 and C1q binding de novo [dn] HLA DSAs are associated with a poor outcome in acute antibody mediated rejection,…
  • 2018 American Transplant Congress

    MERTK Mediates Transplant Tolerance via IFN-a Regulation of MDSCs and Tregs

    L. Zhang, M. DeBerge, E. Thorp, X. Luo.

    Northwestern University Feinberg School of Medicine, Chicago.

    Introduction: MERTK is one of the TAM receptor tyrosine kinases (RTKs) that mediate homeostatic phagocytosis of apoptotic cells, and transmit regulatory signals that modulate immune…
  • 2018 American Transplant Congress

    Liver Transplant Survival Index for Recipients with High MELD Score: A Model for Post-Transplant Survival in Severely Ill Patients

    J. Steggerda,1 M. Bloom,1 C. Bresee,2 D. Malinoski,3 A. Klein,1 K. Kim.1

    1Surgery, Cedars-Sinai Medical Center, Los Angeles, CA; 2Biostatistics, Cedars-Sinai Medical Center, Los Angeles, CA; 3Surgery, Oregon Health Science University, Portland, OR.

    Background: SHARE-35 prioritizes patients with MELD scores ≥35 for regional sharing of liver allografts. Because this policy incentivizes transplantation of sicker patients, this study examines…
  • « Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 113
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences